Related Experiment Videos
Angiotensin AT1 receptor over-expression in hypercholesterolaemia
K Strehlow1, S Wassmann, M Böhm
1Clinic III of Internal Medicine, University of Cologne, Germany.
Annals of Medicine
|October 12, 2000
Summary
High cholesterol increases angiotensin II type 1 (AT1) receptor expression in blood vessels, worsening hypertension and atherosclerosis. Statins may prevent this effect, offering a potential therapeutic link.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Endocrinology
Background:
- The renin-angiotensin system (RAS) and its mediator, angiotensin II, are crucial in regulating blood pressure and vascular function via the angiotensin II type 1 (AT1) receptor.
- Atherosclerosis and hypertension are significant cardiovascular diseases, with hypercholesterolemia being a major risk factor.
- The molecular interplay between hypercholesterolemia and AT1 receptor activity in vascular tissues remains incompletely understood.
Purpose of the Study:
- To investigate the relationship between hypercholesterolemia and the expression of the AT1 receptor in vascular tissues.
- To explore the functional consequences of altered AT1 receptor expression in the context of high cholesterol.
- To determine the impact of HMG-CoA reductase inhibitors on vascular AT1 receptor expression in hypercholesterolemia.
Main Methods:
- Cultured vascular smooth muscle cells and hypercholesterolemic rabbit models were used to assess AT1 receptor expression.
- Functional responses to angiotensin II stimulation were evaluated following changes in AT1 receptor expression.
- AT1 receptor expression was examined in hypercholesterolemic men and its modulation by statin therapy was assessed.
Main Results:
- Low-density lipoprotein (LDL) cholesterol significantly increased AT1 receptor expression in vascular smooth muscle cells and hypercholesterolemic rabbits.
- This up-regulation of AT1 receptors correlated with an enhanced vascular response to angiotensin II.
- Elevated vascular AT1 receptor expression was observed in hypercholesterolemic men and was reduced by HMG-CoA reductase inhibitor treatment.
Conclusions:
- Hypercholesterolemia promotes increased AT1 receptor expression in vascular tissue, potentially contributing to hypertension and atherosclerosis.
- Statins may mitigate cardiovascular risk by preventing the cholesterol-induced up-regulation of vascular AT1 receptors.
- These findings elucidate a key molecular mechanism linking dyslipidemia to cardiovascular pathology and highlight a therapeutic role for RAS blockade and statins.